Interventional Cardiology Market Latest Global Report 2024-2031

Interventional Cardiology Market is estimated to grow at a CAGR of 7.4% during the forecast period 2024-2031 

According to the American Medical Association, interventional cardiology is a specialized branch of medicine within cardiology that focuses on evaluating blood flow and pressure in the coronary arteries and heart chambers. This evaluation is carried out using specialized imaging techniques and other diagnostic tools. Additionally, interventional cardiology involves the use of technical procedures and medications to address abnormalities that may impair the proper functioning of the cardiovascular system. 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/interventional-cardiology-market 

Interventional Cardiology Market Trends 

The global interventional cardiology market is experiencing significant growth, largely propelled by the introduction of new products. These product launches play a pivotal role in driving market expansion. For example, in June 2021, Abbott's XIENCE family of stents received approval from the United States Food and Drug Administration for one-month dual-antiplatelet therapy (DAPT), specifically labeled for high bleeding risk (HBR) patients in the United States. 

Similarly, in May 2020, Philips Image Guided Therapy Corporation's Reconnaissance PV .018 OTW digital IVUS catheter obtained 510(K) approval from the US FDA. Additionally, in March 2021, Medtronic received product approval from the FDA for its Harmony Transcatheter Pulmonary Valve (TPV), offering a minimally invasive treatment option for patients with a typical type of congenital heart defect affecting the right ventricle. 

Furthermore, Abbott launched the Amplatzer Piccolo Occluder in India in June 2021, marking the world's first medical device designed for implantation in extremely small babies (weighing as little as 700 grams) with a minimally invasive procedure for treating patent ductus arteriosus (PDA). 

Moreover, in July 2021, MedAlliance introduced two high-performance balloons, ORIGIN SC and ORIGIN NC, designed for vessel preparation in patients with life-threatening coronary and peripheral arterial disease. These innovations are poised to drive growth in the global interventional cardiology market during the forecast period, showcasing the ongoing advancements and investments in cardiovascular care. 

View Full Report: https://www.datamintelligence.com/research-report/interventional-cardiology-market 

Market Segmentation 

By Type  

By End User 

Market Key Players 

Major players are Abbott, Boston Scientific Corporation, Johnson & Johnson, Medtronic, B.Barun Melsungen, Biosensors International Ltd., Terumo Corporation, Biotronik SE and Co. KG, Edwards Lifesciences Corporation and Cook Medical Inc.